Mechanisms of Drug Resistance in Mycobacterium tuberculosis
Open accessThe DOI matches its Crossref record; 269 of the 269 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–269 of 269
Crystal Structure and Mechanism of Catalysis of a Pyrazinamidase from Pyrococcus horikoshii
Du, X., Wang, W., Kim, R., Yakota, H., Nguyen, H., & Kim, S.-H. (2001) · Biochemistry · doi:10.1021/bi0115479 · Cited by 104
Ribosylation by mycobacterial strains as a new mechanism of rifampin inactivation
Dabbs, E. R., Yazawa, K., Mikami, Y., Miyaji, M., Morisaki, N., Iwasaki, S., & FURIHATA, K. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.4.1007 · Cited by 101
Kremer, L., Dover, L. G., Morbidoni, H. R., Vilchèze, C., Maughan, W. N., Baulard, A. R., Tu, S., Honoré, N., Deretic, V. P., Sacchettini, J. C., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302435200 · Cited by 98
Upton, A. M., Mushtaq, A., Victor, T. C., Sampson, S. L., Sandy, J., Smith, D., van Helden, P. D., & Sim, E. (2001) · Molecular Microbiology · doi:10.1046/j.1365-2958.2001.02648.x · Cited by 96
Trias, J., & Benz, R. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53244-0 · Cited by 95
Bakonytė, D., Baranauskaite, A., Cicenaite, J., Sosnovskaja, A., & Stakėnas, P. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.6.2009-2011.2003 · Cited by 92
Taniguchi, H., Chang, B., Abe, C., Nikaido, Y., Mizuguchi, Y., & Yoshida, S. I. (1997) · Journal of Bacteriology · doi:10.1128/jb.179.15.4795-4801.1997 · Cited by 91
Kempsell, K. E., JI, Y.-E., Estrada-G, I. C. E., Colston, M. J., & Cox, R. A. (1992) · Journal of General Microbiology · doi:10.1099/00221287-138-8-1717 · Cited by 91
Quémard, A., Dessen, A., Sugantino, M., Jacobs, W. R., Sacchettini, J. C., & Blanchard, J. S. (1996) · Journal of the American Chemical Society · doi:10.1021/ja950998b · Cited by 90
Timmins, G. S., Master, S. S., Rusnak, F. M., & Deretic, V. P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.8.3006-3009.2004 · Cited by 90
envM genes of Salmonella typhimurium and Escherichia coli
Turnowsky, F., Fuchs, K., Jeschek, C., & Högenauer, G. (1989) · Journal of Bacteriology · doi:10.1128/jb.171.12.6555-6565.1989 · Cited by 89
Proteome-wide Profiling of Isoniazid Targets in Mycobacterium tuberculosis
Argyrou, A., Jin, L., Siconolfi-Baez, L., Angeletti, R. H., & Blanchard, J. S. (2006) · Biochemistry · doi:10.1021/bi061874m · Cited by 89
Wei, C., Lei, B., Musser, J. M., & Tu, S. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.670-675.2003 · Cited by 89
Shoeb, H. A., Bowman, B. U., Ottolenghi, A. C., & Merola, A. J. (1985) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.27.3.404 · Cited by 88
Parsons, L. M., Salfinger, M., Clobridge, A., Dormandy, J., Mirabello, L. J., Polletta, V. L., Saniç, A., Sinyavskiy, O., Larsen, S. C., Driscoll, J. R., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.6.2218-2225.2005 · Cited by 88
Novel mutation in 16S rRNA associated with streptomycin dependence in Mycobacterium tuberculosis
Honoré, N., Marchal, G., & Cole, S. T. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.3.769 · Cited by 88
Self-citationPowerful bactericidal activity of sparfloxacin (AT-4140) against Mycobacterium tuberculosis in mice
Lalande, V., Truffot-Pernot, C., Paccaly-Moulin, A., Grosset, J. H. E., & Ji, B. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.3.407 · Cited by 88
Sun, Z., Zhang, J., Zhang, X., Wang, S., Zhang, Y., & Li, C. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.10.014 · Cited by 87
Nguyen, M., Quémard, A., Broussy, S., Bernadou, J., & Meunier, B. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2137-2144.2002 · Cited by 86
Mestdagh, M., Fonteyne, P.-A., Realini, L., Rossau, R., Jannes, G., Mijs, W., Smet, K. A. L. D., Portaels, F., & den Eeckhout, E. V. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.9.2317 · Cited by 86
Chemotherapy of Experimental Tuberculosis.
Perlman, H., BROWN, H., & Raiziss, G. W. (1941) · American Review of Tuberculosis and Pulmonary Diseases · Cited by 86
Scorpio, A., Collins, D., Whipple, D. L., Cave, D., Bates, J. H., & Zhang, Y. (1997) · Journal of Clinical Microbiology · doi:10.1128/jcm.35.1.106-110.1997 · Cited by 85
Yu, S., Girotto, S., Lee, C., & Magliozzo, R. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300326200 · Cited by 84
Pagán-Ramos, E., Song, J., McFalone, M., Mudd, M. H., & Deretic, V. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.18.4856-4864.1998 · Cited by 82
Anaerobic incubation conditions enhance pyrazinamide activity against Mycobacterium tuberculosis
Wade, M. M., & Zhang, Y. (2004) · Journal of Medical Microbiology · doi:10.1099/jmm.0.45639-0 · Cited by 80
Seydel, J. K., Schaper, K., Wempe, E., & Cordes, H. P. (1976) · Journal of Medicinal Chemistry · doi:10.1021/jm00226a007 · Cited by 79
Pessolani, M. C., Smith, D. R., Rivoire, B., McCormick, J., Hefta, S. A., Cole, S. T., & Brennan, P. J. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.1.319 · Cited by 79
Self-citationNachamkin, I., Kang, C., & Weinstein, M. P. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.5.894 · Cited by 76
Tarshis, M. S., & WEED, W. A. (1953) · PubMed · doi:10.1164/art.1953.67.3.391 · Cited by 74
Evolution of drug-resistant tuberculosis: a tale of two species.
Iseman, M. D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.7.2428 · Cited by 73
Mycobacterium smegmatis d -Alanine Racemase Mutants Are Not Dependent on d -Alanine for Growth
Chacón, O., Feng, Z., Harris, N., Cáceres, N. E., Adams, L. G., & Barletta, R. G. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.2.47-54.2002 · Cited by 72
RifR mutations in the beginning of the Escherichia coli rpoB gene
Severinov, K., Soushko, M., Goldfarb, A., & Nikiforov, V. (1994) · Molecular and General Genetics MGG · doi:10.1007/bf00283512 · Cited by 68
Kwon, D. H., Kato, M., El-Zaatari, F. A., Osato, M. S., & Graham, D. Y. (2000) · FEMS Microbiology Letters · doi:10.1016/s0378-1097(00)00235-4 · Cited by 67
Susceptibility of Mycobacterium tuberculosis to weak acids
Zhang, Y., Zhang, H., & Sun, Z. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg287 · Cited by 67
Lety, M. A., Nair, S., Berche, P., & Escuyer, V (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.12.2629 · Cited by 65
Phenotypic and Genotypic Characterization of Mycobacterium africanum Isolates from West Africa
Frothingham, R., Strickland, P. L., Bretzel, G., Ramaswamy, S. V., Musser, J. M., & Williams, D. L. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.6.1921-1926.1999 · Cited by 62
Sequences of the envM gene and of two mutated alleles in Escherichia coli
Bergler, H., Högenauer, G., & Turnowsky, F. (1992) · Journal of General Microbiology · doi:10.1099/00221287-138-10-2093 · Cited by 62
Wade, M. M., & Zhang, Y. (2006) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl358 · Cited by 61
Boshoff, H. I., & Mizrahi, V. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.22.5809-5814.1998 · Cited by 61
Isolation of plasmids from mycobacteria
Crawford, J. T., & Bates, J. H. (1979) · Infection and Immunity · doi:10.1128/iai.24.3.979-981.1979 · Cited by 60
Role of Superoxide in Catalase-Peroxidase-Mediated Isoniazid Action against Mycobacteria
Wang, J., Burger, R. M., & Drlica, K. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.3.709 · Cited by 60
Davidson, L. A., & Takayama, K. (1979) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.16.1.104 · Cited by 60
Forbes, M., Kuck, N. A., & Peets, E. A. (1965) · Journal of Bacteriology · doi:10.1128/jb.89.5.1299-1305.1965 · Cited by 59
Topology of the RNA polymerase active center probed by chimeric rifampicin-nucleotide compounds.
Mustaev, A., Zaychikov, E., Severinov, K., Kashlev, M., Polyakov, A., Nikiforov, V, & Goldfarb, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12036 · Cited by 59
Loss of oxyR in Mycobacterium tuberculosis
Deretic, V. P., Song, J., & Pagán-Ramos, E. (1997) · Trends in Microbiology · doi:10.1016/s0966-842x(97)01112-8 · Cited by 58
Iron enhances the antituberculous activity of pyrazinamide
Somoskövi, Á. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh042 · Cited by 58
Oxidative Stress Increases Susceptibility of Mycobacterium tuberculosis to Isoniazid
Bulatović, V. M., Wengenack, N. L., Uhl, J. R., Hall, L., Roberts, G. D., Cockerill, F. R., & Rusnak, F. M. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.9.2765-2771.2002 · Cited by 56
Characterization ofpncAMutations of Pyrazinamide-ResistantMycobacterium tuberculosisin Korea
Lee, K. W., Lee, J. M., & Jung, K. S. (2001) · Journal of Korean Medical Science · doi:10.3346/jkms.2001.16.5.537 · Cited by 55
Payton, M. A., Schartau, P., Hagemeier, C. H., Lucas, S. J., Mushtaq, A., Gifford, C., Pintér, K., & Sim, E. (2001) · Microbiology · doi:10.1099/00221287-147-12-3295 · Cited by 53
Susceptibilities of oxyR regulon mutants of Escherichia coli and Salmonella typhimurium to isoniazid
Rosner, J. L. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.10.2251 · Cited by 51
Hou, L., Osei‐Hyiaman, D., Zhang, Z., Wang, B., YANG, A., & KANO, K. (2000) · Epidemiology and Infection · doi:10.1017/s0950268899003635 · Cited by 48
Pseudomonad replication origins: a paradigm for bacterial origins?
Smith, D. W., Yee, T. W., Baird, C., & Krishnapillai, V. (1991) · Molecular Microbiology · doi:10.1111/j.1365-2958.1991.tb01966.x · Cited by 46
Rosner, J. L., & Storz, G. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.8.1829 · Cited by 43
Kenney, T. J., & Churchward, G. (1994) · Journal of Bacteriology · doi:10.1128/jb.176.19.6153-6156.1994 · Cited by 41
Effect of Ethambutol on the Viable Cell Count in Mycobacterium smegmatis
Kilburn, J. O., & Greenberg, J. (1977) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.11.3.534 · Cited by 40
Morris, S. L., Nair, J., & Rouse, D. A. (1992) · Journal of General Microbiology · doi:10.1099/00221287-138-11-2363 · Cited by 40
Winder, F. G., Collins, P., & Rooney, S. A. (1970) · Biochemical Journal · doi:10.1042/bj1170027pa · Cited by 36
McDermott, P. F., White, D. G., Podglajen, I., Alekshun, M. N., & Levy, S. B. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.11.2995-2998.1998 · Cited by 35
Strain variation in the katG region of Mycobacterium tuberculosis
Zhang, Y., & Young, D. B. (1994) · Molecular Microbiology · doi:10.1111/j.1365-2958.1994.tb01291.x · Cited by 34
Perdigão, J., Macedo, R., Ribeiro, A. C., Brum, L., & Portugal, I. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.09.021 · Cited by 33
Ethambutol inhibition of glucose metabolism in mycobacteria: a possible target of the drug
Silve, G., Valero-Guillén, P. L., Quémard, A., Dupont, M.-A., Daffé, M., & Lanéelle, G. (1993) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.37.7.1536 · Cited by 32
Drug Resistance and the Selection of Therapy for Tuberculosis
Davidson, P. T. (1987) · American Review of Respiratory Disease · doi:10.1164/ajrccm/136.2.255 · Cited by 30
Sareen, M., & Khuller, G. K. (1990) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.34.9.1773 · Cited by 30
Sterling, T. R. (2004) · PubMed · Cited by 30
Broussy, S., Coppel, Y., Nguyen, M., Bernadou, J., & Meunier, B. (2003) · Chemistry - A European Journal · doi:10.1002/chem.200204637 · Cited by 27
Shi, R., Zhang, J., Otomo, K., et al. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00416-07 · Cited by 21
Toward Mapping and Sequencing the Genome of Mycobacterium tuberculosis
Cole, S. T., & Smith, D. R. (2014) · ASM Press eBooks · doi:10.1128/9781555818357.ch16 · Cited by 14
Self-citationDubnau, E., Soares-Appel, S., Huang, T. J., & Jacobs, W. R. (1996) · Gene · doi:10.1016/0378-1119(95)00841-1 · Cited by 13
Falkinham, J. O., & Crawford, J. T. (2014) · ASM Press eBooks · doi:10.1128/9781555818357.ch13 · Cited by 9
Cited by
Dheda, K., Gumbo, T., Maartens, G., Dooley, K. E., McNerney, R., Murray, M., Furin, J., Nardell, E. A., London, L., Lessem, E., et al. (2017) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(17)30079-6 · Cited by 684
Modification of the NADH of the Isoniazid Target (InhA) from Mycobacterium tuberculosis
Rozwarski, D. A., Grant, G. A., Barton, D. H. R., Jacobs, W. R., & Sacchettini, J. C. (1998) · Science · doi:10.1126/science.279.5347.98 · Cited by 682
Brown-Elliott, B. A., Nash, K. A., & Wallace, R. J. (2012) · Clinical Microbiology Reviews · doi:10.1128/cmr.05030-11 · Cited by 541
Almeida Da Silva, P. E., & Palomino, J. C. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr173 · Cited by 532
Pyrazinamide Inhibits Trans-Translation in Mycobacterium tuberculosis
Shi, W., Zhang, X., Jiang, X., Yuan, H., Lee, J. S., Barry, C. E., Wang, H., Zhang, W., & Zhang, Y. (2011) · Science · doi:10.1126/science.1208813 · Cited by 514
Metadata
- Authors
- Heym, B., Philipp, W., & Cole, S. T.
- Venue
- Current Topics in Microbiology and Immunology
- Publisher
- Springer Berlin Heidelberg
- Published
- 1996
- Volume
- 215
- Pages
- 49-69
- ISSN
- 0070-217X (ISSN-L)
- OpenAlex
- W1543200780
- Cited by
- 379
- References
- 269
- FWCI
- 1.68
- Type
- book chapter
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.